Last reviewed · How we verify

NCT05909215

Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

Completed Phase 4 Last updated 18 June 2023
What this trial tests

Phase 4 trial testing Normal saline in Hemodynamic Instability in 105 participants. Completed in 13 December 2021.

Timeline
23 August 2021
Primary endpoint
13 December 2021
13 December 2021

Quick facts

Lead sponsorSindh Institute of Urology and Transplantation
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment105
Start date23 August 2021
Primary completion13 December 2021
Estimated completion13 December 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sindh Institute of Urology and Transplantation

Who can join

Adults 18 to 55, any sex, with Hemodynamic Instability or Tracheal Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two doses of Dexmedetomidine (0.5 µ/kg and 0.75 µ/kg) will be used to attenuate the stress response to laryngoscopy in American Society of Anesthesiology, physical class I patients which will be compared with the placebo-controlled group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Normal saline

Trials testing the same drug.

Other recruiting trials for Hemodynamic Instability

Currently open trials in the same condition.

Other Sindh Institute of Urology and Transplantation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05909215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing